Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Colorcon
Harvard Business School
Merck
Cerilliant
AstraZeneca
Medtronic
Citi

Generated: June 17, 2018

DrugPatentWatch Database Preview

Roche Company Profile

« Back to Dashboard

What is the competitive landscape for ROCHE, and what generic and branded alternatives to ROCHE drugs are available?

ROCHE has sixty-four approved drugs.



Summary for Roche
US Patents:0
Tradenames:50
Ingredients:46
NDAs:64
Patent Litigation for Roche: See patent lawsuits for Roche

Drugs and US Patents for Roche

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche GANTRISIN sulfisoxazole acetyl SYRUP;ORAL 009182-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Roche QUARZAN clidinium bromide CAPSULE;ORAL 010355-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Roche FUZEON enfuvirtide INJECTABLE;SUBCUTANEOUS 021481-001 Mar 13, 2003 RX Yes Yes ➤ Sign Up ➤ Sign Up
Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INJECTION 062510-002 Mar 12, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Roche

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo CYTOVENE ganciclovir CAPSULE;ORAL 020460-002 Dec 12, 1997 4,355,032 ➤ Sign Up
Roche VALIUM diazepam TABLET;ORAL 013263-002 Approved Prior to Jan 1, 1982 4,316,897 ➤ Sign Up
Roche BONIVA ibandronate sodium INJECTABLE;INTRAVENOUS 021858-001 Jan 6, 2006 5,662,918 ➤ Sign Up
Roche TAMIFLU oseltamivir phosphate FOR SUSPENSION;ORAL 021246-001 Dec 14, 2000 5,952,375*PED ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ROCHE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 0.1 mg/mL, 1 mL single dose vial ➤ Subscribe 2007-03-08
➤ Subscribe Injection 1 mg/mL, 4 mL multi-dose vials ➤ Subscribe 2004-07-19
➤ Subscribe Tablets 2.5 mg and 150 mg ➤ Subscribe 2007-05-16
➤ Subscribe For Oral Suspension 200 mg/mL ➤ Subscribe 2011-03-25
➤ Subscribe Oral Suspension 6 mg/mL ➤ Subscribe 2015-06-18
➤ Subscribe Injection 1 mg/mL, 1 mL vials ➤ Subscribe 2004-06-01
➤ Subscribe Injection 1 mg/mL, 3 mL Vial ➤ Subscribe 2007-08-31
➤ Subscribe Capsule 75 mg ➤ Subscribe 2010-11-15
➤ Subscribe Capsules 30 mg and 45 mg ➤ Subscribe 2011-08-02
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
US Army
Healthtrust
Express Scripts
Federal Trade Commission
Moodys
Chubb
Fuji
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.